chr16-2090553-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001009944.3(PKD1):​c.12176C>T​(p.Ala4059Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0715 in 1,609,152 control chromosomes in the GnomAD database, including 4,643 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.057 ( 360 hom., cov: 34)
Exomes 𝑓: 0.073 ( 4283 hom. )

Consequence

PKD1
NM_001009944.3 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.236

Publications

29 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025211573).
BP6
Variant 16-2090553-G-A is Benign according to our data. Variant chr16-2090553-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 256915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.074 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.12176C>T p.Ala4059Val missense_variant Exon 45 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.12176C>T p.Ala4059Val missense_variant Exon 45 of 46 1 NM_001009944.3 ENSP00000262304.4
PKD1ENST00000423118.5 linkc.12173C>T p.Ala4058Val missense_variant Exon 45 of 46 1 ENSP00000399501.1
PKD1ENST00000472577.1 linkn.204C>T non_coding_transcript_exon_variant Exon 2 of 3 2
PKD1ENST00000564313.1 linkn.*212C>T downstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0574
AC:
8730
AN:
152174
Hom.:
360
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0147
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0448
Gnomad ASJ
AF:
0.0916
Gnomad EAS
AF:
0.000771
Gnomad SAS
AF:
0.0593
Gnomad FIN
AF:
0.145
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0758
Gnomad OTH
AF:
0.0497
GnomAD2 exomes
AF:
0.0645
AC:
15475
AN:
239776
AF XY:
0.0672
show subpopulations
Gnomad AFR exome
AF:
0.0119
Gnomad AMR exome
AF:
0.0281
Gnomad ASJ exome
AF:
0.102
Gnomad EAS exome
AF:
0.000276
Gnomad FIN exome
AF:
0.141
Gnomad NFE exome
AF:
0.0793
Gnomad OTH exome
AF:
0.0674
GnomAD4 exome
AF:
0.0730
AC:
106370
AN:
1456860
Hom.:
4283
Cov.:
35
AF XY:
0.0729
AC XY:
52833
AN XY:
724778
show subpopulations
African (AFR)
AF:
0.0120
AC:
400
AN:
33438
American (AMR)
AF:
0.0290
AC:
1295
AN:
44580
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
2736
AN:
26114
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39658
South Asian (SAS)
AF:
0.0599
AC:
5164
AN:
86144
European-Finnish (FIN)
AF:
0.143
AC:
7101
AN:
49610
Middle Eastern (MID)
AF:
0.0617
AC:
353
AN:
5724
European-Non Finnish (NFE)
AF:
0.0767
AC:
85273
AN:
1111286
Other (OTH)
AF:
0.0670
AC:
4040
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
6281
12562
18842
25123
31404
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3116
6232
9348
12464
15580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0573
AC:
8725
AN:
152292
Hom.:
360
Cov.:
34
AF XY:
0.0603
AC XY:
4492
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0147
AC:
610
AN:
41572
American (AMR)
AF:
0.0448
AC:
685
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0916
AC:
318
AN:
3472
East Asian (EAS)
AF:
0.000773
AC:
4
AN:
5176
South Asian (SAS)
AF:
0.0592
AC:
286
AN:
4832
European-Finnish (FIN)
AF:
0.145
AC:
1543
AN:
10608
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0758
AC:
5152
AN:
68006
Other (OTH)
AF:
0.0491
AC:
104
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
414
829
1243
1658
2072
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0723
Hom.:
539
Bravo
AF:
0.0464
TwinsUK
AF:
0.0825
AC:
306
ALSPAC
AF:
0.0778
AC:
300
ESP6500AA
AF:
0.0144
AC:
63
ESP6500EA
AF:
0.0804
AC:
690
ExAC
AF:
0.0657
AC:
7918
Asia WGS
AF:
0.0290
AC:
101
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 02, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Polycystic kidney disease, adult type Benign:2
Apr 22, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 25, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Aug 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Polycystic kidney disease Benign:1
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The c.12176C>T, p.Ala4059Val variant was identified in 6.84 % of 7606 control alleles in the Exome Aggregation Consortium (March 14, 2016). According to ACMG guidelines for variant classification based on allele frequency, category BA1, this variant is considered benign and has not been further reviewed (Richards 2015).

Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
7.5
DANN
Benign
0.82
DEOGEN2
Benign
0.21
T;.
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.077
N
LIST_S2
Benign
0.64
T;T
MetaRNN
Benign
0.0025
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L;.
PhyloP100
0.24
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.61
N;N
REVEL
Benign
0.091
Sift
Benign
0.20
T;T
Sift4G
Uncertain
0.050
T;T
Vest4
0.14
ClinPred
0.00081
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.040
gMVP
0.33
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3209986; hg19: chr16-2140554; COSMIC: COSV51916377; COSMIC: COSV51916377; API